Food intake restriction

Food intake restriction refers to a physiological state or therapeutic intervention characterized by a reduction in total caloric consumption. It is not a single molecular target (such as a specific receptor or enzyme) but rather a systemic biological outcome or phenotype typically aimed at managing obesity and metabolic health. This process is orchestrated by a complex network of signals in the central nervous system, particularly within the hypothalamus, which integrates peripheral hormonal cues like insulin, leptin, and ghrelin to regulate appetite and energy expenditure [NIH, 2021]. Pharmacological agents induce food intake restriction by targeting various receptors involved in this network, most notably the Glucagon-like peptide 1 receptor (GLP-1R) and the Melanocortin 4 receptor (MC4R). While food intake restriction is highly effective for improving glycemic control and reducing cardiovascular risk factors, clinical management is required to prevent complications such as malnutrition, muscle wasting, and potential psychological impacts related to disordered eating [PubMed, 2021; StatPearls, 2023].

Other names

Caloric restrictionDietary restrictionAppetite suppressionEnergy intake reductionAnorectic effect

Food intake restriction is achieved pharmacologically by modulating neuroendocrine circuits in the hypothalamus. Drugs act as agonists on anorexigenic pathways (such as the Glucagon-like peptide 1 receptor and Melanocortin 4 receptor) or as modulators of neurotransmitters (like norepinephrine and dopamine) to enhance satiety signals and suppress orexigenic hunger signals [StatPearls, 2023; PubMed, 2022].